Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: A real-world study in China.

Authors: Lei Mao, Juan Wang, Mengjia Song, Yi Que, Yu Zhang, Feifei Sun, Jia Zhu, Junting Huang, Suying Lu, Zijun Zhen, Yizhuo Zhang

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e22010

Source: Full article

---

Abstract

e22010